HCM · NASDAQ · Drug Manufacturers - Specialty & Generic

HUTCHMED (ADR) (HCM)

Develops targeted therapies and immunotherapies, commercializing medicines in China and through global partners.

$14.22
vs last close+0.15 (+1.03%)
  1. Syndio Acquires Embrace.ai

    Business Wire